
Aster DM Healthcare Q2 Results 2025 Highlights: Net Profit Surged 13.59% & Revenue Up 10.20% YoY
Click and Sign Up to Get Live Updates on Q2 Results
Updated: 10 Nov 2025 • 6:42 pm
Posted by:

Aster DM Healthcare Q2 Results FY26: During Q2 FY26, Aster DM Healthcare’s profit increased 13.59% YoY, while revenue increased by 13.59% YoY. The company posted robust numbers, with Q2 PAT at ₹110 crores and revenue at ₹1,197.21 crores. Aster DM Healthcare announced its Q2 results on 6th November 2025.
Aster DM Healthcare Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30-09-2025 | 30-09-2024 | |
| Revenue from Operations | ₹1,197.21 | ₹1,086.44 |
| Profit Before Tax (PBT) | ₹278.09 | ₹254.98 |
| Profit After Tax (PAT) | ₹110 | ₹96.84 |
(Figures in crores)
Aster DM Healthcare Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-09-2025 | 30-09-2024 | |
| Revenue from Operations | ₹681.81 | ₹604.68 |
| Profit Before Tax (PBT) | ₹194.45 | ₹175.74 |
| Profit After Tax (PAT) | ₹104.61 | ₹89.84 |
(Figures in crores)
Aster DM Healthcare Q2 Results FY26 Highlights (Q2 FY26 vs FY25)
- Aster DM Healthcare clocked Q2 FY26 consolidated revenue of ₹1,197.21 crores vs ₹1,086.44 crores.
- On the profit front, Aster DM Healthcare earned a consolidated PAT of ₹110 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹96.84 crore.
- According to the consolidated figures, Aster DM Healthcare’s quarterly PAT increased by 13.59% YoY, while revenue increased by 10.20%.
- Aster DM Healthcare clocked Q2 FY26 standalone revenue of ₹690.02 crores vs ₹643.69 crores.
- On the profit front, Aster DM Healthcare earned a standalone PAT of ₹104.61 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹89.84 crore.
- According to the standalone figures, Aster DM Healthcare’s quarterly PAT increased by 13.59% YoY, while revenue increased by 10.20%.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Aster DM Healthcare Share Price Performance
On the opening bell on 10th November 2025, Aster DM Healthcare shares opened at ₹548.75 per share. However, the initial gains have since eroded, and Aster DM Healthcare shares are currently trading at ₹682.10 per share, which is lower than the opening price.
Considering the long-term achievements, Aster DM Healthcare shares have yielded returns of approximately 24.30% over the past six months, and one-year returns stand at 55.55%. Over the maximum timeframe, Aster DM Healthcare shares delivered a 300.41% return to investors.
What Analysts Expect Post Q2 Results?
Following Aster DM Healthcare’s robust Q2 results, analysts expect its share price to rise. According to analysts, Aster DM Healthcare’s share price is expected to reach ₹520.19 per share in the coming year; however, in a downturn, it could fall to ₹500.10 per share. However, one must ignore stock market volatility and invest in Aster DM Healthcare ‘s shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY
Inspira Enterprise India IPO Details: Everything You Should Know about
Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY
HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY
BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here
Recent Articles

Anand Rathi Share and Stock Brokers Share Price: What Could the Next 3 Years Look Like?
15 July 2026

Andhra Cements Share Price Outlook: Where Could It Be by 2030?
15 July 2026

Gold Price Today Rallies Over 2 Percent to $4,063 an Ounce as Weak US Data Boosts Investor Sentiment on 15 July 2026
15 July 2026

Where Will Anlon Healthcare Share Price Be in the Next 3 Years?
15 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Anand Rathi Share and Stock Brokers Share Price: What Could the Next 3 Years Look Like?
Andhra Cements Share Price Outlook: Where Could It Be by 2030?
Gold Price Today Rallies Over 2 Percent to $4,063 an Ounce as Weak US Data Boosts Investor Sentiment on 15 July 2026
Where Will Anlon Healthcare Share Price Be in the Next 3 Years?
Where Will Archidply Industries Share Price Be in the Next 3 Years?
Popular this week
Anand Rathi Share and Stock Brokers Share Price: What Could the Next 3 Years Look Like?
Andhra Cements Share Price Outlook: Where Could It Be by 2030?
Gold Price Today Rallies Over 2 Percent to $4,063 an Ounce as Weak US Data Boosts Investor Sentiment on 15 July 2026
Where Will Anlon Healthcare Share Price Be in the Next 3 Years?
Where Will Archidply Industries Share Price Be in the Next 3 Years?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





